SCHEMBL29377736

SCHEMBL29377736

CC1(C)COC(c2cc(C(=O)Nc3ccc(N4CC(C)(C)c5cc(F)ccc54)nc3)cc(F)c2O)OC1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KCNQ3 O43525 5/20 0.40
▸ KCNQ2 O43526 5/20 0.40
▸ KLKB1 P03952 1/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ BACE1 P56817 5/20 0.34
▸ HDAC3 O15379 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ BACE2 Q9Y5Z0 4/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22466007 1.00 KCNQ3 (0.40) KCNQ3KCNQ2KLKB1RAB9ANPC1
SCHEMBL29375344 0.85 KCNQ3 (0.43) KCNQ3KCNQ2RAB9ASMN1; SMN2BACE1
SCHEMBL22465890 0.85 KCNQ3 (0.43) KCNQ3KCNQ2RAB9ASMN1; SMN2BACE1
SCHEMBL29377859 0.83 KCNQ3 (0.48) KCNQ3KCNQ2RAB9ANPC1SMN1; SMN2
SCHEMBL29377323 0.81 KCNQ3 (0.47) KCNQ3KCNQ2RAB9ANPC1SMN1; SMN2
SCHEMBL22465850 0.81 KCNQ3 (0.47) KCNQ3KCNQ2RAB9ANPC1SMN1; SMN2
SCHEMBL22465932 0.79 KCNQ3 (0.51) KCNQ3KCNQ2RAB9ANPC1SMN1; SMN2
SCHEMBL29377113 0.79 KCNQ3 (0.51) KCNQ3KCNQ2RAB9ANPC1SMN1; SMN2
SCHEMBL22465914 0.78 KCNQ3 (0.43) KCNQ3KCNQ2RAB9ASMN1; SMN2BACE1
SCHEMBL29549562 0.78 KCNQ3 (0.43) KCNQ3KCNQ2RAB9ASMN1; SMN2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114025847-B Compounds and compositions as modulators of TLR signaling 神经孔疗法股份有限公司 2024-05-24 — — CN disclosed
EP-3946599-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING Neuropore Therapies, Inc. (US) 2022-02-09 — — EP disclosed
CN-114025847-A Compounds and compositions as modulators of TLR signaling 神经孔疗法股份有限公司 2022-02-08 — — CN disclosed
Send feedback